169 related articles for article (PubMed ID: 32738439)
1. Removing a difficult-to-separate byproduct by Capto L affinity chromatography during the purification of a WuXiBody-based bispecific antibody.
Wang Y; Chen X; Wang Y; Li Y
Protein Expr Purif; 2020 Nov; 175():105713. PubMed ID: 32738439
[TBL] [Abstract][Full Text] [Related]
2. Protein L chromatography: A useful tool for monitoring/separating homodimers during the purification of IgG-like asymmetric bispecific antibodies.
Chen X; Wang Y; Wang Y; Li Y
Protein Expr Purif; 2020 Nov; 175():105711. PubMed ID: 32738435
[TBL] [Abstract][Full Text] [Related]
3. Removing light chain-missing byproducts and aggregates by Capto MMC ImpRes mixed-mode chromatography during the purification of two WuXiBody-based bispecific antibodies.
Wan Y; Zhang T; Wang Y; Wang Y; Li Y
Protein Expr Purif; 2020 Nov; 175():105712. PubMed ID: 32738441
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin-binding protein-based affinity chromatography in bispecific antibody purification: Functions beyond product capture.
Li Y
Protein Expr Purif; 2021 Dec; 188():105976. PubMed ID: 34537355
[TBL] [Abstract][Full Text] [Related]
5. Removing a light-chain missing byproduct by MMC ImpRes mixed-mode chromatography under weak partitioning mode in purifying a WuXiBody-based bispecific antibody.
Zhang T; Wan Y; Duan J; Li Y
Protein Expr Purif; 2021 Oct; 186():105927. PubMed ID: 34111551
[TBL] [Abstract][Full Text] [Related]
6. A potential downstream platform approach for WuXiBody-based IgG-like bispecific antibodies.
Guo G; Han J; Wang Y; Li Y
Protein Expr Purif; 2020 Sep; 173():105647. PubMed ID: 32334139
[TBL] [Abstract][Full Text] [Related]
7. Removing a single-arm species by Fibro PrismA in purifying an asymmetric IgG-like bispecific antibody.
Zhang T; Wan Y; Wang Y; Li Y
Protein Expr Purif; 2021 Jun; 182():105847. PubMed ID: 33588033
[TBL] [Abstract][Full Text] [Related]
8. IgG-like bispecific antibody platforms with built-in purification-facilitating elements.
Li Y
Protein Expr Purif; 2021 Dec; 188():105955. PubMed ID: 34416361
[TBL] [Abstract][Full Text] [Related]
9. A brief introduction of IgG-like bispecific antibody purification: Methods for removing product-related impurities.
Li Y
Protein Expr Purif; 2019 Mar; 155():112-119. PubMed ID: 30513344
[TBL] [Abstract][Full Text] [Related]
10. Comparing the relative robustness of byproduct removal by wash and by elution in column chromatography for the purification of a bispecific antibody.
Wan Y; Zhang T; Wang Y; Li Y
Protein Expr Purif; 2021 Jan; 177():105762. PubMed ID: 32971297
[TBL] [Abstract][Full Text] [Related]
11. Removal of half antibody, hole-hole homodimer and aggregates during bispecific antibody purification using MMC ImpRes mixed-mode chromatography.
Tang J; Zhang X; Chen T; Wang Y; Li Y
Protein Expr Purif; 2020 Mar; 167():105529. PubMed ID: 31698035
[TBL] [Abstract][Full Text] [Related]
12. Removing half antibody byproduct by Protein A chromatography during the purification of a bispecific antibody.
Chen X; Wang Y; Li Y
Protein Expr Purif; 2020 Aug; 172():105635. PubMed ID: 32268171
[TBL] [Abstract][Full Text] [Related]
13. Application of pH-salt dual gradient elution in purifying a WuXiBody-based bispecific antibody by MMC ImpRes mixed-mode chromatography.
Wan Y; Wang Y; Zhang T; Zhang S; Wang Y; Li Y
Protein Expr Purif; 2021 May; 181():105822. PubMed ID: 33429037
[TBL] [Abstract][Full Text] [Related]
14. Purification of common light chain IgG-like bispecific antibodies using highly linear pH gradients.
Sharkey B; Pudi S; Wallace Moyer I; Zhong L; Prinz B; Baruah H; Lynaugh H; Kumar S; Wittrup KD; Nett JH
MAbs; 2017; 9(2):257-268. PubMed ID: 27937066
[TBL] [Abstract][Full Text] [Related]
15. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
Shen J; Vil MD; Jimenez X; Iacolina M; Zhang H; Zhu Z
J Biol Chem; 2006 Apr; 281(16):10706-14. PubMed ID: 16481314
[TBL] [Abstract][Full Text] [Related]
16. Assessing four subdomain-specific affinity resins' capability to separate half-antibody from intact bispecific antibody.
Chen W; Zhang T; Wan Y; Li Y
Protein Expr Purif; 2022 Oct; 198():106124. PubMed ID: 35661701
[TBL] [Abstract][Full Text] [Related]
17. "BIClonals": Production of Bispecific Antibodies in IgG Format in Transiently Transfected Mammalian Cells.
Litvak-Greenfeld D; Vaks L; Dror S; Nahary L; Benhar I
Methods Mol Biol; 2019; 1904():431-454. PubMed ID: 30539485
[TBL] [Abstract][Full Text] [Related]
18. Separating antibody species containing one and two kappa light chain constant region by KappaSelect affinity chromatography.
Qin T; Wang Y; Li Y
Protein Expr Purif; 2020 Jul; 171():105618. PubMed ID: 32151654
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody.
Cao M; Parthemore C; Jiao Y; Korman S; Aspelund M; Hunter A; Kilby G; Chen X
J Pharm Sci; 2021 Aug; 110(8):2904-2915. PubMed ID: 33894207
[TBL] [Abstract][Full Text] [Related]
20. Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development.
Ollier R; Wassmann P; Monney T; Ries Fecourt C; Gn S; C A V; Ayoub D; Stutz C; Gudi GS; Blein S
MAbs; 2019; 11(8):1464-1478. PubMed ID: 31462177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
